✦ LIBER ✦

Pilot Study of Interferon-α with and without Amantadine for the Treatment of Hepatitis C in HIV Co-infected Individuals on Antiretroviral Therapy

✍ Scribed by H. Sax; A. Friedl; E. Renner; M.H. Steuerwald; R. Weber; for the Swiss HIV Cohort Study

Publisher: Springer-Verlag
Year: 2001
Tongue: English
Weight: 152 KB
Volume: 29
Category: Article
ISSN: 0300-8126
DOI: 10.1007/s15010-001-2045-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination therapy with thymosin α1 and

Combination therapy with thymosin α1 and interferon for the treatment of chronic hepatitis C infection: A randomized, placebo-controlled double-blind trial

✍ Kenneth E. Sherman; Maria Sjogren; Robin L. Creager; Melissa A. Damiano; Stephen 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 1 views

Hepatitis C is a major cause of liver disease leading to cirrhosis. Although interferon (IFN) is the only approved therapy, treatment is characterized by low response rates and dose-limiting side effects. We evaluated the addition of thymosin ␣1 (TA1), an immunomodulatory peptide, to the standard tr

A phase III study of radiation therapy p

A phase III study of radiation therapy plus carmustine with or without recombinant interferon-α in the treatment of patients with newly diagnosed high-grade glioma

✍ Jan C. Buckner; Paula J. Schomberg; William L. McGinnis; Terrence L. Cascino; Be 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB 👁 2 views

Types of human leukocyte antigen and dec

Types of human leukocyte antigen and decrease in HCV core antigen in serum for predicting efficacy of interferon-Α in patients with chronic hepatitis C: analysis by a prospective study

✍ Hidetomo Muto; Eiji Tanaka; Akihiro Matsumoto; Kaname Yoshizawa; Kendo Kiyosawa; 📂 Article 📅 2004 🏛 Springer Japan 🌐 English ⚖ 220 KB